Laboratory diagnosis of cutaneous and visceral leishmaniasis: current and future methods
Leishmaniasis is a neglected tropical disease with two main clinical forms: cutaneous and
visceral leishmaniasis. Diagnosis of leishmaniasis is still a challenge, concerning the …
visceral leishmaniasis. Diagnosis of leishmaniasis is still a challenge, concerning the …
When inflammatory stressors dramatically change, disease phenotypes may transform between autoimmune hematopoietic failure and myeloid neoplasms
XC Zhao, B Ju, NN Xiu, XY Sun, FJ Meng - Frontiers in Immunology, 2024 - frontiersin.org
Aplastic anemia (AA) and hypoplastic myelodysplastic syndrome are paradigms of
autoimmune hematopoietic failure (AHF). Myelodysplastic syndrome and acute myeloid …
autoimmune hematopoietic failure (AHF). Myelodysplastic syndrome and acute myeloid …
Leishmania infantum amastin protein incorporated in distinct adjuvant systems induces protection against visceral leishmaniasis
PAF Ribeiro, DL Vale, DS Dias, DP Lage… - Cytokine, 2020 - Elsevier
The control measures against visceral leishmaniasis (VL) include a precise diagnosis of
disease, the treatment of human cases, and reservoir and vector controls. However, these …
disease, the treatment of human cases, and reservoir and vector controls. However, these …
Investigation of the antigenicity and protective efficacy of Leishmania promastigote membrane antigens in search of potential diagnostic and vaccine candidates …
Background Visceral leishmaniasis (VL), is a parasitic disease that causes serious medical
consequences if treatment is delayed. Despite a decline in the number of VL cases in the …
consequences if treatment is delayed. Despite a decline in the number of VL cases in the …
An introduction to dynamic nucleoporins in Leishmania species: Novel targets for tropical-therapeutics
As an ailment, leishmaniasis is still an incessant challenge in neglected tropical diseases
and neglected infections of poverty worldwide. At present, the diagnosis and treatment to …
and neglected infections of poverty worldwide. At present, the diagnosis and treatment to …
Recombinant endonuclease III protein from Leishmania infantum associated with Th1-type adjuvants is immunogenic and induces protection against visceral …
DP Lage, AS Machado, CS Freitas, DL Vale… - Molecular …, 2023 - Elsevier
Vaccination against visceral leishmaniasis (VL) should be considered as a safe and
effective measure to disease control; however, few vaccines are available against canine VL …
effective measure to disease control; however, few vaccines are available against canine VL …
RETRACTED: Leishmania-Specific Promiscuous Membrane Protein Tubulin Folding Cofactor D Divulges Th1/Th2 Polarization in the Host via ERK-1/2 and p38 …
Visceral leishmaniasis (VL)-related mortality and morbidity imposes a great deal of health
concern across the globe. The existing anti-leishmanial drug regimen generally fails to …
concern across the globe. The existing anti-leishmanial drug regimen generally fails to …